Immunome Inc. (NASDAQ:IMNM) is held by 176 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 1,772,260 | 30.44% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | 3,493,007 | 26.75% | $0.00 |
| T. Rowe Price Investment Management, Inc. | 31 Dec, 2025 | 0 | 6,220,377 | 73.89% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -68,334 | -21.73% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 1,144,788 | 23.39% | $0.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 0 | 2,210,448 | 45.82% | $0.00 |
| Redmile Group, LLC | 31 Dec, 2025 | 0 | 695,000 | 13.84% | $0.00 |
| Enavate Sciences GP, LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| PRIMECAP MANAGEMENT CO/CA/ | 31 Dec, 2025 | 0 | 1,667,432 | 55.25% | $0.00 |
| READYSTATE ASSET MANAGEMENT LP | 31 Dec, 2025 | 0 | 524,920 | 39.82% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 1,064,027 | 37.95% | $0.00 |
| Sofinnova Investments, Inc. | 31 Dec, 2025 | 0 | 1,182,426 | 271.17% | $0.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 0 | 3,009,423 | 432.05% | $0.00 |
| Woodline Partners LP | 31 Dec, 2025 | 0 | 300,669 | 23.59% | $0.00 |
| Jpmorgan Chase & Co | 31 Dec, 2025 | 0 | 2,790,541 | 4,279.58% | $0.00 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 1,126,210 | 0.00% | $0.00 |
| EcoR1 Capital, LLC | 31 Dec, 2025 | 0 | -1,223,825 | -30.00% | $0.00 |
| Polar Capital Holdings Plc | 31 Dec, 2025 | 0 | -265,412 | -25.07% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 466,806 | 24.64% | $0.00 |
| ExodusPoint Capital Management, LP | 31 Dec, 2025 | 0 | 779,578 | 0.00% | $0.00 |